Education & training
Caring for Kids New to Canada - Immunizations: Bringing Newcomer Children Up to Date
Ensuring that a child new to Canada is up to date with all immunizations poses unique challenges. Confirming or updating childhood immunizations is not a part of the immigration medical examination, and it cannot be assumed that newly arrived children are completely immunized.
Immunization for meningococcal serogroup B: What does the practitioner need to know?
Most invasive meningococcal disease in Canada is now caused by serogroup B organisms. A vaccine directed against this serogroup (4CMenB) is newly licensed in Canada. It is hoped that this document will be useful to clinicians when faced with questions from parents.
Immunization information on the internet : can you trust what you read?
This fact sheet can help you decide if vaccine information you find on the Internet is accurate.
Information sur la vaccination qu'on trouve sur Internet : Est-ce qu'on peut se fier à ce qu'on lit?
Ce feuillet d’information a pour but de vous aider à décider si l’information sur les vaccins que vous trouvez sur Internet est exacte.
La vaccination : la mise à jour de l'immunisation des enfants néo-canadiens
Lorsqu’on veut s’assurer qu’un enfant nouvellement arrivé au Canada a reçu tous les vaccins prévus, on fait face à des problèmes particuliers. L’examen médical aux fins de l’'immigration n’inclut pas la confirmation ou la mise à jour de la vaccination. Il ne faut pas présumer que les enfants nouvellement arrivés ont reçu tous les vaccins.
La vaccination contre le méningocoque du sérogroupe B : ce que le praticien doit savoir
Au Canada, la plupart des méningococcies invasives sont désormais causées par des organismes du sérogroupe B. Un vaccin conçu contre ce sérogroupe (4CMenB) vient d'être homologué au Canada. Le présent document peut être utile aux cliniciens qui devront répondre aux questions des parents.
Qu'est-ce que le CCMTMV?
Le Comité consultatif de la médecine tropicale et de la médecine des voyages (CCMTMV) est un organe consultatif d'experts qui assiste l'ASPC en ce qui a trait aux conseils relatifs à la santé-voyage et pour les professionnels des soins de santé.
Relevé des maladies transmissibles au Canada (RMTC)
Vaccine Safety: Examine the Evidence
The safety and effectiveness of vaccines are under constant study. Because vaccines are designed to be given routinely during well-child care visits, they must be extraordinarily safe. Safety testing begins as soon as a new vaccine is contemplated, continues until it is approved by the FDA, and is monitored indefinitely after licensure. The American Academy of Pediatrics (AAP) works closely with the Centers for Disease Control and Prevention (CDC, US) to make recommendations for vaccine use.
Assessing vaccine safety within Ontario's Universal Influenza Immunization Program, 2012-2013 to 2014-2015
Objective: To summarize adverse events following immunization (AEFIs) reported after receipt of influenza vaccines administered within the Universal Influenza Immunization Program in Ontario.
Conclusion: This assessment found a low rate of reported adverse events following influenza vaccines administered in Ontario. Most reported events were mild and resolved completely. The findings were consistent with the very good safety profile of influenza vaccines.